BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator), covering 2023-06-27 to 2023-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults [Phase 2]